P248 Subcutaneous secukinumab 150 mg provides rapid and...

P248 Subcutaneous secukinumab 150 mg provides rapid and sustained relief in total and nocturnal back pain, morning stiffness and fatigue in patients with active AS over 4 years

Marzo-Ortega, Helena, Miceli-Richard, Corinne, Gill, Sonja, Magery, Marina, Machado, Paula G. P, Shete, Abhijit, Wang, Jianyuan, Rohrer, Susanne, Deodhar, Atul
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
59
Journal:
Rheumatology
DOI:
10.1093/rheumatology/keaa111.241
Date:
April, 2020
File:
PDF, 63 KB
2020
Conversion to is in progress
Conversion to is failed